Requiring FDA Guidances Does Not Always Advance The Science, Gene Therapy Director Says
OTAT Director Wilson Bryan says important cell and gene therapy guidances came from clear community needs, not user fee program requirements.
OTAT Director Wilson Bryan says important cell and gene therapy guidances came from clear community needs, not user fee program requirements.